Abhinav A. Shukla net worth and biography

Abhinav Shukla Biography and Net Worth

Chief Technical Officer of Shattuck Labs

Dr. Shukla joined Shattuck in June of 2021 as Chief Technical Officer. He brings a background of demonstrated leadership across the full spectrum of biologics process development and manufacturing to Shattuck. Most recently Dr. Shukla served as the Chief Technical Operations Officer at Redpin Therapeutics, where he was responsible for all aspects of process, analytical and formulation development, and cGMP manufacturing. Previously, he held several senior leadership positions, including Vice President of Manufacturing at CRISPR Therapeutics, Vice President and Head of Biologics Process Development at Shire, Senior Vice President of Process Development and Manufacturing at KBI Biopharma, and in senior scientific roles at Bristol-Myers Squibb and Amgen prior to KBI. Throughout his career, Dr. Shukla has been involved in over 75 investigational new drug applications as well as the commercialization of several therapeutics, including Yervoy®, Orencia®, and Nulojix®. Dr. Shukla received his doctorate in Chemical and Biochemical Engineering from Rensselaer Polytechnic Institute and his undergraduate degree from the Indian Institute of Technology, Delhi.

What is Abhinav A. Shukla's net worth?: The estimated net worth of Abhinav A. Shukla is at least $402.23 thousand as of May 12th, 2026. Dr. Shukla owns 81,258 shares of Shattuck Labs stock worth more than $402,227 as of June 21st. This net worth approximation does not reflect any other investments that Dr. Shukla may own. Learn More about Abhinav A. Shukla's net worth.
How do I contact Abhinav A. Shukla?: The corporate mailing address for Dr. Shukla and other Shattuck Labs executives is , , . Shattuck Labs can also be reached via phone at 512-900-4690 and via email at [email protected]. Learn More on Abhinav A. Shukla's contact information.
Has Abhinav A. Shukla been buying or selling shares of Shattuck Labs?: During the last quarter, Abhinav A. Shukla has sold $14,244.32 in Shattuck Labs stock. Most recently, Abhinav A. Shukla sold 2,032 shares of the business's stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $7.01, for a transaction totalling $14,244.32. Following the completion of the sale, the insider now directly owns 81,258 shares of the company's stock, valued at $569,618.58. Learn More on Abhinav A. Shukla's trading history.
Who are Shattuck Labs' active insiders?: Shattuck Labs' insider roster includes Mona Ashiya (Director), Tyler Brous (Director), Josiah Hornblower (Director), Andrew Neill (CFO), Taylor Schreiber (CEO), Abhinav Shukla (Chief Technical Officer), Clay Siegall (Director), and Erin Thomson (General Counsel). Learn More on Shattuck Labs' active insiders.
Are insiders buying or selling shares of Shattuck Labs?: In the last twelve months, Shattuck Labs insiders bought shares 3 times. They purchased a total of 12,674,754 shares worth more than $11,222,660.98. In the last twelve months, insiders at the sold shares 2 times. They sold a total of 32,032 shares worth more than $212,544.32. The most recent insider tranaction occured on June, 9th when Director Clay B Siegall bought 62,500 shares worth more than $250,000.00. Insiders at Shattuck Labs own 8.8% of the company. Learn More about insider trades at Shattuck Labs.
Information on this page was last updated on 6/9/2026.

Abhinav A. Shukla Insider Trading History at Shattuck Labs

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/12/2026	Sell	2,032	$7.01	$14,244.32	81,258

Abhinav A. Shukla Buying and Selling Activity at Shattuck Labs

Shattuck Labs Company Overview

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.

Today's Range

Now: $4.95

$4.73

$5.08

50 Day Range

MA: $6.16

$3.90

$7.88

2 Week Range

Now: $4.95

$0.71

$8.33

Volume

1,221,914 shs

Average Volume

1,028,974 shs

Market Capitalization

$379.57 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.08